Notice of Meetings, 10014-10015 [2017-02624]

Download as PDF 10014 Federal Register / Vol. 82, No. 26 / Thursday, February 9, 2017 / Notices placed on the FTC’s public record and available to the public for routine inspection and copying. See FTC–I–6 (Public Records–FTC). (2) As required by the FOIA, records that have been ‘‘frequently requested’’ and disclosed under the FOIA within the meaning of that Act, as determined by the FTC, are made available to the public for routine inspection and copying. See FTC–I–6 (Public Records– FTC). (3) Disclosure to the National Archives and Records Administration, Office of Government Information Services (OGIS), to the extent necessary to fulfill its responsibilities in 5 U.S.C. 552(h), to review administrative agency policies, procedures, and compliance with the Freedom of Information Act (FOIA), and to facilitate OGIS’s offering of mediation services to resolve disputes between persons making FOIA requests and administrative agencies. See also Appendix I for other ways that the Privacy Act permits the FTC to use or disclose system records outside the agency. controls (e.g., firewalls). FTC buildings are guarded and monitored by security personnel, cameras, ID checks, and other physical security measures. RECORD ACCESS PROCEDURES: See Appendix II. CONTESTING RECORD PROCEDURES: See Appendix II. NOTIFICATION PROCEDURES: See Appendix II. EXEMPTIONS PROMULGATED FOR THE SYSTEM: Records contained in this system that have been placed on the FTC public record are available upon request, as discussed above. However, pursuant to 5 U.S.C. 552a(k)(2), records in this system, which reflect records that are contained in other systems of records that are designated as exempt, are exempt from the requirements of subsections (c)(3), (d), (e)(1), (e)(4)(G), (H), (I), and (f) of 5 U.S.C. 552a. See § 4.13(m) of the FTC Rules of Practice, 16 CFR 4.13(m). HISTORY: POLICIES AND PRACTICES FOR STORAGE OF RECORDS: 73 FR 33591–33634 (June 12, 2008). Records are maintained electronically using a commercial software application run on the agency’s internal servers. Temporary paper files are destroyed once the request is complete. By direction of the Commission. Donald S. Clark, Secretary. [FR Doc. 2017–02664 Filed 2–8–17; 8:45 am] BILLING CODE 6750–01–P POLICIES AND PRACTICES FOR RETRIEVAL OF RECORDS: Indexed by name of requesting party and subject matter of request. Records can also be searched by name, address, phone number, fax number, and email of the requesting party, subject matter of the request, requestor organization, FOIA number, and staff member assigned to the request. POLICIES AND PRACTICES FOR RETENTION AND DISPOSAL OF RECORDS: Records are retained and disposed of in accordance with General Records Schedule 14.11–14.15, issued by the National Archives and Records Administration. sradovich on DSK3GMQ082PROD with NOTICES ADMINISTRATIVE, TECHNICAL, AND PHYSICAL SAFEGUARDS: Requests, appeals, and responses available to the public, as described above. Access to nonpublic system records is restricted to FTC personnel or contractors whose responsibilities require access. Nonpublic paper records are temporary, maintained in lockable file cabinets or offices, and destroyed once the request is complete. Access to electronic records is controlled by ‘‘user ID’’ and password combination and other electronic access or network VerDate Sep<11>2014 18:11 Feb 08, 2017 Jkt 241001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice of five AHRQ subcommittee meetings. AGENCY: The subcommittees listed below are part of AHRQ’s Health Services Research Initial Review Group Committee. Grant applications are to be reviewed and discussed at these meetings. Each subcommittee meeting will commence in open session before closing to the public for the duration of the meeting. DATES: See below for dates of meetings: 1. Healthcare Effectiveness and Outcomes Research (HEOR) Date: February 8th–9th, 2017 (Open from 8:30 a.m. to 9:00 a.m. on February 8th and closed for remainder of the meeting) 2. Healthcare Safety and Quality Improvement Research (HSQR) SUMMARY: Frm 00032 Fmt 4703 (below specifics where each hotel will be held) ADDRESS: Hilton Rockville, 1750 Rockville Pike, Rockville, MD 20857 (to obtain a roster of members, agenda or minutes of the non-confidential portions of the meetings.) FOR FURTHER INFORMATION CONTACT: Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research Education and Priority Populations, Agency for Healthcare Research and Quality (AHRQ), 5600 Fishers Lane, Rockville, Maryland 20857, Telephone (301) 427–1554. SUPPLEMENTARY INFORMATION: Notice of Meetings PO 00000 Date: February 15th–16th, 2017 (Open from 8:00 a.m. to 8:30 a.m. on February 15th and closed for remainder of the meeting) 3. Health System and Value Research (HSVR) Date: February 22nd–23rd, 2017 (Open from 8:30 a.m. to 9:00 a.m. on February 22nd and closed for remainder of the meeting) 4. Health Care Research and Training (HCRT) Date: February 23rd–24th 2017 (Open from 8:00 a.m. to 8:30 a.m. on February 23rd and closed for remainder of the meeting) 5. Healthcare Information Technology Research (HITR) Date: February 22nd–24th, 2017 (Open from 5:00 p.m. to 5:30 p.m. on February 22nd and closed for remainder of the meeting) Sfmt 4703 In accordance with section 10(a)(2) of the Federal Advisory Committee Act (5 U.S.C. App. 2), AHRQ announces meetings of the above-listed scientific peer review groups, which are subcommittees of AHRQ’s Health Services Research Initial Review Group Committees. Each subcommittee meeting will commence in open session before closing to the public for the duration of the meeting. The subcommittee meetings will be closed to the public in accordance with the provisions set forth in 5 U.S.C. App. 2 section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6) The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. E:\FR\FM\09FEN1.SGM 09FEN1 Federal Register / Vol. 82, No. 26 / Thursday, February 9, 2017 / Notices Agenda items for these meetings are subject to change as priorities dictate. Sharon B. Arnold, Acting Director. [FR Doc. 2017–02624 Filed 2–8–17; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Patient Safety Organizations: Voluntary Relinquishment From the Fresenius Medical Care PSO, LLC Agency for Healthcare Research and Quality (AHRQ), Department of Health and Human Services (HHS). ACTION: Notice of delisting. AGENCY: The Patient Safety and Quality Improvement Act of 2005, 42 U.S.C. 299b–21 to b–26, (Patient Safety Act) and the related Patient Safety and Quality Improvement Final Rule, 42 CFR part 3 (Patient Safety Rule), published in the Federal Register on November 21, 2008, 73 FR 70732– 70814, establish a framework by which hospitals, doctors, and other health care providers may voluntarily report information to Patient Safety Organizations (PSOs), on a privileged and confidential basis, for the aggregation and analysis of patient safety events. The Patient Safety Rule authorizes AHRQ, on behalf of the Secretary of HHS, to list as a PSO an entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be ‘‘delisted’’ by the Secretary if it is found to no longer meet the requirements of the Patient Safety Act and Patient Safety Rule, when a PSO chooses to voluntarily relinquish its status as a PSO for any reason, or when a PSO’s listing expires. AHRQ has accepted a notification of voluntary relinquishment from the Fresenius Medical Care PSO, LLC of its status as a PSO, and has delisted the PSO accordingly. The Fresenius Medical Care PSO, LLC submitted this request for voluntary relinquishment after receiving a Notice of Preliminary Finding of Deficiency. DATES: The directories for both listed and delisted PSOs are ongoing and reviewed weekly by AHRQ. The delisting was effective at 12:00 Midnight ET (2400) on January 6, 2017. ADDRESSES: Both directories can be accessed electronically at the following HHS Web site: http:// www.pso.ahrq.gov/listed. sradovich on DSK3GMQ082PROD with NOTICES VerDate Sep<11>2014 18:11 Feb 08, 2017 Jkt 241001 Eileen Hogan, Center for Quality Improvement and Patient Safety, AHRQ, 5600 Fishers Lane, Room 06N94B, Rockville, MD 20857; Telephone (toll free): (866) 403–3697; Telephone (local): (301) 427–1111; TTY (toll free): (866) 438–7231; TTY (local): (301) 427–1130; Email: pso@ahrq.hhs.gov. SUPPLEMENTARY INFORMATION: Background Agency for Healthcare Research and Quality SUMMARY: FOR FURTHER INFORMATION CONTACT: The Patient Safety Act authorizes the listing of PSOs, which are entities or component organizations whose mission and primary activity are to conduct activities to improve patient safety and the quality of health care delivery. HHS issued the Patient Safety Rule to implement the Patient Safety Act. AHRQ administers the provisions of the Patient Safety Act and Patient Safety Rule relating to the listing and operation of PSOs. The Patient Safety Rule authorizes AHRQ to list as a PSO an entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be ‘‘delisted’’ if it is found to no longer meet the requirements of the Patient Safety Act and Patient Safety Rule, when a PSO chooses to voluntarily relinquish its status as a PSO for any reason, or when a PSO’s listing expires. Section 3.108(d) of the Patient Safety Rule requires AHRQ to provide public notice when it removes an organization from the list of federally approved PSOs. AHRQ has accepted a notification from the Fresenius Medical Care PSO, LLC, a component entity of Fresenius Medical Holdings, Inc., PSO number P0081, to voluntarily relinquish its status as a PSO. Accordingly, the Fresenius Medical Care PSO, LLC was delisted effective at 12:00 Midnight ET (2400) on January 6, 2017. AHRQ notes that the Fresenius Medical Care PSO, LLC submitted this request for voluntary relinquishment following receipt of the Notice of Preliminary Finding of Deficiency sent to the PSO on December 12, 2016. Fresenius Medical Care PSO, LLC has patient safety work product (PSWP) in its possession. The PSO will meet the requirements of section 3.108(c)(2)(i) of the Patient Safety Rule regarding notification to providers that have reported to the PSO. In addition, according to sections 3.108(c)(2)(ii) and 3.108(b)(3) of the Patient Safety Rule regarding disposition of PSWP, the PSO has 90 days from the effective date of delisting and revocation to complete the disposition of PSWP that is currently in the PSO’s possession. PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 10015 More information on PSOs can be obtained through AHRQ’s PSO Web site at http://www.pso.ahrq.gov. Sharon B. Arnold, Acting Director. [FR Doc. 2017–02623 Filed 2–8–17; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Scientific Information Request on Treatment-Resistant Depression: A Narrative and Systematic Review of Definitions and Methods in Clinical Research Studies Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Request for Scientific Information Submissions. AGENCY: The Agency for Healthcare Research and Quality (AHRQ) is seeking scientific information submissions from the public. Scientific information is being solicited to inform our review of Treatment-Resistant Depression: A Narrative and Systematic Review of Definitions and Methods in Clinical Research Studies, which is currently being conducted by the AHRQ’s Evidence-based Practice Centers (EPC) Program. Access to published and unpublished pertinent scientific information will improve the quality of this review. AHRQ is conducting this systematic review pursuant to Section 902(a) of the Public Health Service Act, 42 U.S.C. 299a(a). DATES: Submission Deadline on or before March 13, 2017. ADDRESSES: Email submissions: SEADS@epc-src.org. Print submissions: Mailing Address: Portland VA Research Foundation, Scientific Resource Center, ATTN: Scientific Information Packet Coordinator, P.O. Box 69539, Portland, OR 97239. Shipping Address (FedEx, UPS, etc.): Portland VA Research Foundation, Scientific Resource Center, ATTN: Scientific Information Packet Coordinator, 3710 SW U.S. Veterans Hospital Road, Mail Code: R&D 71, Portland, OR 97239. FOR FURTHER INFORMATION CONTACT: Ryan McKenna, Telephone: 503–220– 8262 ext. 51723 or Email: SIPS@epcsrc.org. SUMMARY: The Agency for Healthcare Research and Quality has commissioned the SUPPLEMENTARY INFORMATION: E:\FR\FM\09FEN1.SGM 09FEN1

Agencies

[Federal Register Volume 82, Number 26 (Thursday, February 9, 2017)]
[Notices]
[Pages 10014-10015]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-02624]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Agency for Healthcare Research and Quality


Notice of Meetings

AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.

ACTION: Notice of five AHRQ subcommittee meetings.

-----------------------------------------------------------------------

SUMMARY: The subcommittees listed below are part of AHRQ's Health 
Services Research Initial Review Group Committee. Grant applications 
are to be reviewed and discussed at these meetings. Each subcommittee 
meeting will commence in open session before closing to the public for 
the duration of the meeting.

DATES: See below for dates of meetings:
1. Healthcare Effectiveness and Outcomes Research (HEOR)
    Date: February 8th-9th, 2017 (Open from 8:30 a.m. to 9:00 a.m. on 
February 8th and closed for remainder of the meeting)
2. Healthcare Safety and Quality Improvement Research (HSQR)
    Date: February 15th-16th, 2017 (Open from 8:00 a.m. to 8:30 a.m. on 
February 15th and closed for remainder of the meeting)
3. Health System and Value Research (HSVR)
    Date: February 22nd-23rd, 2017 (Open from 8:30 a.m. to 9:00 a.m. on 
February 22nd and closed for remainder of the meeting)
4. Health Care Research and Training (HCRT)
    Date: February 23rd-24th 2017 (Open from 8:00 a.m. to 8:30 a.m. on 
February 23rd and closed for remainder of the meeting)
5. Healthcare Information Technology Research (HITR)
    Date: February 22nd-24th, 2017 (Open from 5:00 p.m. to 5:30 p.m. on 
February 22nd and closed for remainder of the meeting)

ADDRESS: (below specifics where each hotel will be held)

Hilton Rockville, 1750 Rockville Pike, Rockville, MD 20857

FOR FURTHER INFORMATION CONTACT: (to obtain a roster of members, agenda 
or minutes of the non-confidential portions of the meetings.)

Mrs. Bonnie Campbell, Committee Management Officer, Office of 
Extramural Research Education and Priority Populations, Agency for 
Healthcare Research and Quality (AHRQ), 5600 Fishers Lane, Rockville, 
Maryland 20857, Telephone (301) 427-1554.

SUPPLEMENTARY INFORMATION: 
    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (5 U.S.C. App. 2), AHRQ announces meetings of the above-
listed scientific peer review groups, which are subcommittees of AHRQ's 
Health Services Research Initial Review Group Committees. Each 
subcommittee meeting will commence in open session before closing to 
the public for the duration of the meeting. The subcommittee meetings 
will be closed to the public in accordance with the provisions set 
forth in 5 U.S.C. App. 2 section 10(d), 5 U.S.C. 552b(c)(4), and 5 
U.S.C. 552b(c)(6) The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

[[Page 10015]]

    Agenda items for these meetings are subject to change as priorities 
dictate.

Sharon B. Arnold,
Acting Director.
[FR Doc. 2017-02624 Filed 2-8-17; 8:45 am]
 BILLING CODE 4160-90-P